Sebastian-TradingExpertsEU

Biontech AG Outbreak - First COVID-19 human vaccine trial test

Long
NASDAQ:BNTX   BioNTech SE
Hey fellow Trader,
The uprising Biotechnology company from BNTX Mainz, Germany is on its final steps from developing a vaccine for the actual Bio-weapon health crisis from the "new flu" .
With Rolf Zinkernagel a brilliant Scientiests that can proudly say to win a nobelprice and a strong financial background , from big names in the Pharmaceutical field.

When BioNTech AG announced to start with the first human vaccine tests after getting an approval in Europa , a US approval should follow shortly after also.
We should expect News from those test in end May/june and if they´ve managed to create a proven vaccine afterwards im staying LONG in this Outbreak because its Trending and the Chances are high for a good R/R.

A Golden Cross is forming and the Overall Stock is positive and with a low beta so less correlation risk in this given "Crazy Market" .
So with a break of the 56 level we should see a strong move up.

Goals are high and i think it could touch the 100 mark again with reactive move down to given support levels if they arent successful with their vaccine Therapy.
STOPLOSS tight at 49,45

I hope this was helpful but it only displays my opionion and no financial adivce is given here.

Sincerly,
Sebastian
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.